Literature DB >> 11532018

Specific inhibition of interleukin-4-dependent Stat6 activation by an intracellularly delivered peptide.

S Stolzenberger1, M Haake, A Duschl.   

Abstract

The transcription factor Stat6 (signal transducer and activator of transcription 6) is activated following stimulation with interleukin (IL)-4 or IL-13. Stat6 binds via a single SH2 domain first to tyrosine-phosphorylated motifs in the IL-4Ralpha chain, and then to another Stat6 molecule, which results in the formation of active dimers. We show here that a peptide derived from the Stat6-binding region of IL-4Ralpha (Stat6BP) is an effective inhibitor when it is delivered into cells by coupling with a membrane-permeable peptide. Stat6BP completely inhibited IL-4 dependent phosphorylation of Stat6, as well as basal and IL-4 stimulated transcription from a reporter gene construct with a Stat6-dependent promoter, while IL-3 and IL-4 dependent phosphorylation of Stat5 was not affected. The inhibitory effect of Stat6BP was transient, but could be prolonged by treating the cells with the phosphatase inhibitor pervanadate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11532018     DOI: 10.1046/j.1432-1327.2001.02417.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  6 in total

Review 1.  Therapeutic modulators of STAT signalling for human diseases.

Authors:  Gabriella Miklossy; Tyvette S Hilliard; James Turkson
Journal:  Nat Rev Drug Discov       Date:  2013-08       Impact factor: 84.694

2.  Synthesis and in Vitro Evaluation of a Peptidomimetic Inhibitor Targeting the Src Homology 2 (SH2) Domain of STAT6.

Authors:  Pietro Morlacchi; Pijus K Mandal; John S McMurray
Journal:  ACS Med Chem Lett       Date:  2013-12-04       Impact factor: 4.345

Review 3.  The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers--a review and hypothesis.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2004-01       Impact factor: 2.332

4.  Targeting the Src Homology 2 (SH2) Domain of Signal Transducer and Activator of Transcription 6 (STAT6) with Cell-Permeable, Phosphatase-Stable Phosphopeptide Mimics Potently Inhibits Tyr641 Phosphorylation and Transcriptional Activity.

Authors:  Pijus K Mandal; Pietro Morlacchi; J Morgan Knight; Todd M Link; Gilbert R Lee; Roza Nurieva; Divyendu Singh; Ankur Dhanik; Lydia Kavraki; David B Corry; John E Ladbury; John S McMurray
Journal:  J Med Chem       Date:  2015-11-09       Impact factor: 7.446

Review 5.  Vaccinia virus pathogenicity in atopic dermatitis is caused by allergen-induced immune response that prevents the antiviral cellular and humoral immunity.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2003-12       Impact factor: 2.198

Review 6.  Recent Advances in the Inhibition of the IL-4 Cytokine Pathway for the Treatment of Allergen-Induced Asthma.

Authors:  Oliver Massey; Cenk Suphioglu
Journal:  Int J Mol Sci       Date:  2021-12-20       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.